EUVIMEDEUVIMED entdecken
Crossref

Analysis of the Dynamics of Cognitive Impairments and Expression of Caspase Cascade Genes in Preclinical Stages of Parkinsonism Modeled Using α-Synuclein Oligomers

M A Gruden, V I Inokenteva, O A Solovieva, N P Mikhailova, A M Ratmirov, V V Sherstnev, Z I Storozheva

Bulletin of Experimental Biology and Medicine · 2024

DOI: 10.1007/s10517-024-06199-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Experimental Biology and Medicine, 2024. Verfasst von M A Gruden und 6 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia. mgruden@mail.ru. Hauptthemen laut MEDLINE: Caspase 3, alpha-Synuclein, Mice, Inbred C57BL, Cognitive Dysfunction. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The behavioral effects of α-synuclein oligomers were studied at various times after its chronic intranasal administration to 75-day-old C57BL/6J mice in comparison with the dynamics of changes in the transcriptional activity of caspases genes (Casp9, Casp8, and Casp3) in the hippocampus, frontal cortex, and cerebellum. The negative effects of α-synuclein oligomers on exploratory activity and short-term memory in the novel object recognition test were most pronounced after 90 days from the end of administration, while after 1 and 270 days, partial compensation of the studied cognitive functions was observed. Analysis of the expression of caspase genes suggests that early compensatory mechanisms are associated with suppression of the effector caspase-3 gene expression along with increased activity of the genes encoding initiator caspases-9 and -8. Late compensation processes are associated with a decrease in the activity of initiator caspases in the frontal cortex and cerebellum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caspase 3alpha-SynucleinMice, Inbred C57BLCognitive DysfunctionCaspase 8Caspase 9HippocampusCerebellumAnimalsMiceFrontal LobeMaleDisease Models, AnimalParkinsonian DisordersMemory, Short-Term

Stichwörter der Autor:innen

Casp9, Casp8, Casp3 genescognitive activitydelayed effectsmiceα-synuclein oligomers

Substanzen

Caspase 3alpha-SynucleinCaspase 8Caspase 9Casp3 protein, mouseCasp9 protein, mouseCasp8 protein, mouse

Autor:innen und Institutionen

  • Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia. mgruden@mail.ru.
  • Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia.

Zitieren

APA

Gruden, M. A., Inokenteva, V. I., Solovieva, O. A., Mikhailova, N. P., Ratmirov, A. M., Sherstnev, V. V., & Storozheva, Z. I. (2024). Analysis of the Dynamics of Cognitive Impairments and Expression of Caspase Cascade Genes in Preclinical Stages of Parkinsonism Modeled Using α-Synuclein Oligomers. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06199-5

Vancouver

Gruden MA, Inokenteva VI, Solovieva OA, Mikhailova NP, Ratmirov AM, Sherstnev VV, et al. Analysis of the Dynamics of Cognitive Impairments and Expression of Caspase Cascade Genes in Preclinical Stages of Parkinsonism Modeled Using α-Synuclein Oligomers. Bulletin of Experimental Biology and Medicine. 2024. doi:10.1007/s10517-024-06199-5

BibTeX
@article{Gruden2024,
  author = {Gruden, M A and Inokenteva, V I and Solovieva, O A and Mikhailova, N P and Ratmirov, A M and Sherstnev, V V and Storozheva, Z I},
  title = {Analysis of the Dynamics of Cognitive Impairments and Expression of Caspase Cascade Genes in Preclinical Stages of Parkinsonism Modeled Using α-Synuclein Oligomers},
  journal = {Bulletin of Experimental Biology and Medicine},
  year = {2024},
  doi = {10.1007/s10517-024-06199-5}
}
Kostenlos starten →